Alzheimer's Disease Prevention Trial

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute on Aging (NIA)
• Treatments: Estrogens; Progesterone

Criteria

Inclusion Criteria:

• Healthy women 65 or older with a family history of memory problems not currently on estrogen.

Exclusion Criteria:

• Significant neurological impairment

• Current estrogen use

• History of breast cancer